Wynne K, Park AJ, Small CJ, et al
Compare the PlexusDx approach: see the Weight Management Protocols semaglutide and tirzepatide with the genetic context most telehealth programs skip
There was a significant reduction in the risk of CRC in patients who received GLP-1RAs when compared with all other antidiabetic medications, except alpha-glucosidase or DPP-4i, in which there was a non-significant reduced risk
Schedule a non-urgent appointment if you experience new or worsening anxiety symptoms, recurrent episodes of intense fear or discomfort accompanied by physical symptoms (palpitations, sweating, trembling, shortness of breath), persistent nausea or vomiting that interferes with medication adherence or nutrition, or symptoms that consistently occur in temporal relationship to tirzepatide injections
That gives people the ability to see the negative patents and the courage to make positive and lasting change